UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs.

Loading...
Thumbnail Image

Embargo End Date

Authors

Gozdecka, M
Meduri, E
Mazan, M
Tzelepis, K
Dudek, M
Knights, AJ
Pardo, M
Yu, L
Choudhary, JS
Metzakopian, E
Iyer, V
Yun, H
Park, N
Varela, I
Bautista, R
Collord, G
Dovey, O
Garyfallos, DA
De Braekeleer, E
Kondo, S
Cooper, J
Göttgens, B
Bullinger, L
Northcott, PA
Adams, D
Vassiliou, GS
Huntly, BJP

Document Type

Journal Article

Date

2018-06-01

Date Accepted

2018-03-19

Abstract

The histone H3 Lys27-specific demethylase UTX (or KDM6A) is targeted by loss-of-function mutations in multiple cancers. Here, we demonstrate that UTX suppresses myeloid leukemogenesis through noncatalytic functions, a property shared with its catalytically inactive Y-chromosome paralog, UTY (or KDM6C). In keeping with this, we demonstrate concomitant loss/mutation of KDM6A (UTX) and UTY in multiple human cancers. Mechanistically, global genomic profiling showed only minor changes in H3K27me3 but significant and bidirectional alterations in H3K27ac and chromatin accessibility; a predominant loss of H3K4me1 modifications; alterations in ETS and GATA-factor binding; and altered gene expression after Utx loss. By integrating proteomic and genomic analyses, we link these changes to UTX regulation of ATP-dependent chromatin remodeling, coordination of the COMPASS complex and enhanced pioneering activity of ETS factors during evolution to AML. Collectively, our findings identify a dual role for UTX in suppressing acute myeloid leukemia via repression of oncogenic ETS and upregulation of tumor-suppressive GATA programs.

Citation

Nature genetics, 2018, 50 (6), pp. 883 - 894

Source Title

Publisher

NATURE PUBLISHING GROUP

ISSN

1061-4036

eISSN

1546-1718

Research Team

Functional Proteomics Group

Notes